SAN

76.89

-0.91%↓

ARGX

701

-0.82%↓

SHL.DE

34.58

+0.26%↑

FRE

38.84

-2.92%↓

PHIA

23.42

+0.95%↑

SAN

76.89

-0.91%↓

ARGX

701

-0.82%↓

SHL.DE

34.58

+0.26%↑

FRE

38.84

-2.92%↓

PHIA

23.42

+0.95%↑

SAN

76.89

-0.91%↓

ARGX

701

-0.82%↓

SHL.DE

34.58

+0.26%↑

FRE

38.84

-2.92%↓

PHIA

23.42

+0.95%↑

SAN

76.89

-0.91%↓

ARGX

701

-0.82%↓

SHL.DE

34.58

+0.26%↑

FRE

38.84

-2.92%↓

PHIA

23.42

+0.95%↑

SAN

76.89

-0.91%↓

ARGX

701

-0.82%↓

SHL.DE

34.58

+0.26%↑

FRE

38.84

-2.92%↓

PHIA

23.42

+0.95%↑

Home・Aktien・Sartorius AG

Sartorius AG

Geschlossen

BrancheGesundheitswesen

234 -0.81

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

232

Max

237.9

Schlüsselkennzahlen
By Trading Economics
Einkommen	26M 56M
Verkäufe	-29M 899M
KGV Branchendurchschnitt	93.22 49.701
EPS	1.21
Dividendenrendite	0.34
Gewinnspanne	6.251
Angestellte	14,242
EBITDA	-9.6M 258M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+12.67% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	0.34% 2.39%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-1.5B 15B
Vorheriger Eröffnungskurs	234.81
Vorheriger Schlusskurs	234

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

227 / 232 Unterstützung & Widerstand

Sartorius AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Sartorius AG Prognose

Kursziel

By TipRanks

12.67% Vorteil

12-Monats-Prognose

Durchschnitt 265 EUR 12.67%

Hoch 307 EUR

Tief 220 EUR

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sartorius AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

13 ratings

Buy

Halten

Sell

Basierend auf 13 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Sartorius AG – Dist abgegeben haben.

Technischer Score

By Trading Central

227 / 232Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Sartorius AG

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.